This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Abbvie Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations by Inventor Wen Zhou
Introduction
Wen Zhou is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of inflammatory bowel diseases. With a total of 2 patents, his work focuses on innovative methods that aim to improve patient outcomes.
Latest Patents
Wen Zhou's latest patents include groundbreaking methods for treating Crohn's disease and ulcerative colitis. The present disclosure is directed to methods for treating Crohn's disease, specifically aimed at inducing clinical remission and/or endoscopic improvement using a JAK1 inhibitor. In certain embodiments, patients are administered an induction dose of the JAK1 inhibitor to achieve clinical remission, followed by at least one maintenance dose thereafter. Additionally, the methods extend to treating ulcerative colitis using the same JAK1 inhibitor, showcasing the versatility and potential impact of his innovations.
Career Highlights
Wen Zhou is currently associated with AbbVie Inc., a leading biopharmaceutical company. His role at AbbVie allows him to collaborate with other experts in the field and contribute to the development of novel therapies. His work is characterized by a commitment to advancing medical science and improving the quality of life for patients suffering from chronic conditions.
Collaborations
Wen Zhou has worked alongside talented colleagues, including Aileen L Pangan and Ana Paula Machado De Lacerda. These collaborations enhance the research environment and foster innovation within the team.
Conclusion
Wen Zhou's contributions to the field of medicine through his patents and collaborations highlight his dedication to improving treatment options for patients with Crohn's disease and ulcerative colitis. His innovative approaches are paving the way for future advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
